Enforcement Briefing, October 18, 2026

Psychiatrist receives prison sentence for signing unsupported DME orders

Summary

Steven Powell received 12 months and a day in prison after signing brace orders without evaluating beneficiaries. The scheme generated more than $1.9 million in Medicare claims; $761,202.75 was paid and ordered as restitution. Rapid signing of prefilled orders was central to the conduct.

What changed

On October 13, former New Hampshire physician Steven Powell was sentenced to 12 months and a day in federal prison on one count of healthcare fraud. The licensed psychiatrist prescribed durable medical equipment without seeing, speaking with, or otherwise meaningfully evaluating the beneficiaries. His orders supported approximately 1,400 fraudulent Medicare claims totaling more than $1.9 million. Medicare paid $761,202.75, and the court ordered restitution in that same amount.

Between December 2018 and March 2019, Powell signed brace orders for more than 500 beneficiaries, often approving multiple braces per person. DOJ described prepopulated orders approved in volumes and timeframes incompatible with meaningful review. In one example, he completed more than 100 pages requiring 75 signatures in just over a minute. The case therefore connects the authenticity of the clinical assessment with the timing and pattern of electronic approvals, rather than treating a signed order alone as sufficient support.

Why it matters

Order signatures can conceal an absent clinical assessment. DME suppliers and clinical networks need evidence that a prescriber actually evaluated the beneficiary and supported each ordered item.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, FBI, HHS-OIG

Entities

Steven Powell

Action type

Criminal resolution

Event date

Oct 13, 2026

Alleged conduct

Signing medically unnecessary DME orders without meaningful beneficiary evaluation, supporting fraudulent Medicare claims.

Resolution

Sentenced to 12 months and a day in prison and ordered to pay $761,202.75 restitution. More than $1.9 million was claimed; $761,202.75 was paid.

What to do nextReview high-volume DME ordering relationships, confirm encounter documentation and clinical support, and investigate implausibly rapid approvals or multiple-brace patterns before relying on signed orders.

• Validate the underlying clinical encounter and necessity of each item.
• Use signature timing and ordering-pattern anomalies to identify unsupported approvals.

1. Recommended internal target: identify DME prescribers with unusually rapid approvals, repeated templates or multiple items per beneficiary and select records for review. Compliance · due Oct 23, 2026
2. Recommended internal target: reconcile selected orders with actual encounters, medical necessity and beneficiary confirmation; escalate unsupported claims for counsel-directed assessment. Clinical Operations · due Oct 30, 2026

Permalink: #steven-powell-dme-fraud-sentence · Development ID GC-2026-0350

DME nominee owner admits laundering Medicare fraud proceeds

Summary

Leo Anzivino Jr. pleaded guilty to laundering proceeds from a DME operation that billed Medicare more than $6 million. Nominee ownership, forged physician orders and beneficiary returns accompanied transfers of $1,494,938.09. Sentencing is scheduled for January 21, 2027.

What changed

Leo Anzivino Jr. pleaded guilty on October 13 to one count of money laundering conspiracy connected to Advanced Medical Supply Corp. in New Hampshire. Advanced submitted more than $6 million in Medicare claims for equipment beneficiaries did not need and doctors had not prescribed, using fake physician orders. Medicare paid more than $3 million. Anzivino is scheduled for sentencing on January 21, 2027; the reported 10-year maximum is a statutory exposure, not an imposed sentence.

Anzivino appeared as Advanced's owner on Medicare enrollment documents and falsely certified bank ownership information while others were the actual beneficial owners and managers. Beneficiaries returned equipment with statements that they had not ordered it. After one bank questioned proposed recipient companies, Anzivino opened another account. Even after learning of impending billing revocation, he wired $1,494,938.09 in three transactions over five weeks. The government separately seized approximately $353,768.29 in 2024; that seizure is not a restitution judgment.

Why it matters

Enrollment records, bank ownership information, beneficiary complaints and payment movements can reveal a common scheme even when each appears to involve a different operational team.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, HHS-OIG, FBI, IRS-CI, DCIS

Entities

Leo Anzivino Jr., Advanced Medical Supply Corp.

Action type

Criminal resolution

Event date

Oct 13, 2026

Alleged conduct

Concealing beneficial ownership and laundering proceeds of fraudulent Medicare DME claims supported by fake physician orders.

Resolution

Guilty plea to money laundering conspiracy; sentencing scheduled January 21, 2027. No sentence or restitution award was reported.

What to do nextReconcile supplier ownership disclosures with actual control and payment recipients. Route unsolicited-equipment returns and bank concerns into a shared fraud assessment, including review of transfers following enrollment deficiencies.

• Validate beneficial ownership beyond nominal enrollment entries.
• Connect beneficiary returns, bank concerns and enrollment deficiencies across teams.

1. Recommended internal target: compare DME beneficial owners, managers, enrollment disclosures and payment-account control for inconsistent or nominee arrangements. Provider Enrollment · due Oct 23, 2026
2. Recommended internal target: connect equipment returns and ordering complaints to payment holds, physician-order validation and a documented escalation decision. Compliance · due Oct 30, 2026

Permalink: #anzivino-dme-nominee-owner-money-laundering-plea · Development ID GC-2026-0351

CVS settles controlled-substance and false-claims allegations for $315 million plus interest

Summary

CVS executed settlements totaling $315 million in principal, plus interest on the civil settlement, without admitting liability. A related DEA agreement establishes controls for covered CVS retail pharmacies through August 15, 2032. Its operational requirements and implementation clock apply to CVS under the agreement.

What changed

DOJ announced October 13 that CVS Pharmacy Inc. and related entities settled allegations involving unlawful controlled-substance dispensing and federal healthcare claims for conduct from October 17, 2013 through December 2, 2025. The executed agreements, whose latest signatures are dated October 13, divide the $315 million principal into $126 million under the Controlled Substances Act and $189 million under the civil settlement. The latter adds annual interest of 3.63% from September 8, 2026 and designates $94.5 million as compensatory restitution. Both agreements expressly state that CVS denies the allegations, admits no liability and has not been found liable. DOJ alleged unresolved prescribing warning signs and linked dispensing failures to corporate performance metrics, staffing and restrictions on sharing prescriber concerns.

The attached DEA memorandum applies to CVS Pharmacy retail stores registered with DEA that fill prescriptions for its defined designated controlled substances; Caremark specialty and mail-order pharmacies are expressly outside its scope. Its implementation date is 30 days after full execution on October 13, and its term runs through August 15, 2032. Required controls include documenting resolution of identified prescription warning signs, protecting pharmacists' professional refusal decisions, reviewing unresolved prescriber concerns and blocking prescribers unless prohibited by federal or state law, proactive pharmacy reviews, an anonymous hotline, annual controlled-substance inventories and compliance reporting to DEA. These are CVS agreement requirements. They provide concrete control examples for other organizations without imposing the same agreement-specific reporting schedules or implementation dates across the industry.

Why it matters

The resolution connects controlled-substance dispensing, federal reimbursement and corporate operating practices. Its detailed safeguards illustrate how professional judgment, shared prescriber information, documented warning-sign resolution and monitoring can function together. The settlement's allocation, interest and CVS-specific scope must remain distinct from generally applicable law.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, DEA, HHS-OIG

Entities

CVS Pharmacy Inc., Related CVS defendant entities

Action type

Settlement

Event date

Oct 13, 2026

Alleged conduct

Unlawful controlled-substance dispensing and federal reimbursement claims involving allegedly invalid prescriptions, unresolved warning signs and corporate operating practices.

Resolution

Executed settlements require $126 million under the CSA and $189 million under the civil agreement, totaling $315 million principal. The civil amount accrues 3.63% annual interest from September 8, 2026 and includes $94.5 million compensatory restitution. CVS denies liability. A retail-pharmacy DEA memorandum begins 30 days after October 13 execution and runs through August 15, 2032.

What to do nextAssess whether staffing, productivity expectations, prescriber-alert sharing and documentation allow pharmacists to resolve controlled-substance concerns before dispensing and billing. Compare relevant controls with the executed memorandum while separately identifying the organization's own legal requirements. The playbook dates below are recommended internal review targets.

• Evaluate staffing and incentives alongside dispensing controls.
• Document resolution of identified prescription warning signs and preserve pharmacists' professional judgment.
• Connect prescriber concerns with enterprise review and dispensing-system controls.
• Distinguish settlement principal, interest and restitution allocations.
• Apply the memorandum's scope and deadlines to CVS rather than presenting them as industry-wide requirements.

1. Recommended internal target: map controlled-substance escalation, staffing coverage, performance incentives and the ability to share prescriber concerns across locations. Compliance · due Oct 23, 2026
2. Recommended internal target: sample higher-risk dispensing patterns for documented warning-sign resolution and professional judgment; record remediation owners and distinguish internal recommendations from CVS-specific agreement terms. Clinical Operations · due Oct 30, 2026

Permalink: #cvs-controlled-substance-false-claims-settlement · Development ID GC-2026-0352

Excluded beneficial owner admits false Medicaid psychotherapy claims

Summary

Ronnie Lorenzo Robinson Jr. admitted using concealed ownership and other people's identifiers to submit psychotherapy claims through The Fisher of Men Project. Approximately $735,000 was claimed and $440,000 paid. His prior Medicaid exclusion makes actual ownership and operational control central to the case.

What changed

Ronnie Lorenzo Robinson Jr. pleaded guilty on October 15 to healthcare fraud involving North Carolina Medicaid psychotherapy claims. According to the plea documents, approximately $735,000 in false reimbursement claims produced approximately $440,000 in payments to his company. Robinson was released on bond, and no sentencing date had been set. The reported 10-year maximum is potential statutory punishment, not a sentence already imposed.

Robinson admitted that he was the beneficial owner of The Fisher of Men Project, LLC but concealed that ownership because he had previously been excluded from Medicaid. Another person was presented as the company's owner. He obtained identifying information belonging to medical professionals and Medicaid recipients and used it to submit claims for psychotherapy that was not provided, without those individuals' knowledge or authorization. The ownership concealment and unauthorized use of clinician identities were integral to the admitted billing conduct.

Why it matters

Screening nominal owners alone can miss an excluded person exercising beneficial ownership or control. Claims also require validation that the identified clinician actually authorized and delivered the reported service.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, FBI, North Carolina Medicaid Investigations Division

Entities

Ronnie Lorenzo Robinson Jr., The Fisher of Men Project, LLC

Action type

Criminal resolution

Event date

Oct 15, 2026

Alleged conduct

Concealing ownership after Medicaid exclusion and using clinician and beneficiary identifiers to claim psychotherapy services not provided.

Resolution

Guilty plea; approximately $735,000 claimed and $440,000 paid. No sentence or restitution award reported.

What to do nextReconcile behavioral-health ownership disclosures with actual operational and financial control. Validate clinician authorization, service records and recipient receipt where claims patterns or identity-use concerns indicate possible fabricated psychotherapy.

• Screen actual beneficial owners and operational controllers.
• Verify clinician authorization and the underlying psychotherapy encounter.

1. Recommended internal target: compare disclosed behavioral-health owners and managers with actual control, payment authority and exclusion-screening records. Provider Enrollment · due Oct 23, 2026
2. Recommended internal target: review suspicious psychotherapy claims against clinician authorization and encounter evidence, escalating unauthorized identity use. Compliance · due Oct 30, 2026

Permalink: #robinson-fisher-of-men-medicaid-fraud-plea · Development ID GC-2026-0354

DMERx owner receives 19 years for fraudulent order platform

Summary

Brett Blackman received a 19-year sentence for a platform used to generate fraudulent medical orders and connect suppliers with kickback-funded telemedicine approvals. More than $1 billion was billed and more than $450 million paid. Restitution and forfeiture remain for later determination.

What changed

Brett Blackman was sentenced on October 14 to 19 years in prison, according to DOJ's October 15 announcement. Following an April jury conviction, the sentence addressed conspiracies involving healthcare fraud, wire fraud, kickbacks and false healthcare statements. The operation billed Medicare and other federal healthcare programs more than $1 billion, and insurers paid more than $450 million. Those totals describe scheme billing and payments; Blackman's restitution and forfeiture obligations will be determined later.

Blackman's HealthSplash acquired DMERx, an internet platform used to generate false physician orders. Suppliers, marketers and telemedicine companies exchanged kickbacks for signed orders, although doctors had little or no meaningful interaction with beneficiaries. DOJ described orders falsely recording tests that require an in-person examination, sham contracts and removal of telemedicine references to avoid audits. Medicare was fraudulently billed for braces for more than 346,000 beneficiaries. The platform's workflow and altered documentation helped scale the scheme beyond any single prescriber or supplier.

Why it matters

A vendor's electronic order can carry fabricated clinical representations into downstream claims. Procurement, clinical review and billing controls need to address referral economics, encounter authenticity and preservation of accurate provenance.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks, Health-tech

Jurisdiction

Federal

Agencies

DOJ, HHS-OIG, FBI, VA-OIG, DCIS

Entities

Brett Blackman, HealthSplash, DMERx

Action type

Criminal resolution

Event date

Oct 14, 2026

Alleged conduct

Operating a platform that generated fraudulent medical orders, facilitated kickbacks and concealed absent or inadequate patient encounters.

Resolution

19-year prison sentence following jury conviction. More than $1 billion billed and more than $450 million paid; restitution and forfeiture not yet determined.

What to do nextReview DME and telemedicine platforms for paid-referral arrangements, unverifiable encounters, implausible exam documentation and changes that hide how care occurred. Validate orders independently before treating platform output as billing support.

• Validate the clinical encounter behind vendor-generated orders.
• Review referral compensation and preserve accurate encounter provenance.
• Investigate documentation manipulation intended to avoid audits.

1. Recommended internal target: inventory vendors linking patient leads, telemedicine approvals and DME fulfillment, including compensation and referral flows. Compliance · due Oct 23, 2026
2. Recommended internal target: trace selected platform orders to real encounters and audit history, checking whether examination claims or telemedicine provenance were altered. Clinical Operations · due Oct 30, 2026

Permalink: #blackman-dmerx-software-fraud-sentence · Development ID GC-2026-0355

Patient recruiter admits opioid distribution through clinics and pharmacies

Summary

Jose Llerena pleaded guilty to a conspiracy involving more than 87,000 oxycodone pills, with 3,735 attributed personally to him. Paid recruits obtained unnecessary prescriptions that were filled at participating pharmacies. The plea highlights coordinated recruitment, cash payments and resale indicators.

What changed

Jose Llerena pleaded guilty on October 14 to conspiracy to distribute a controlled substance, DOJ reported October 15. The conspiracy involved more than 87,000 oxycodone 30 mg pills, while Llerena was personally responsible for distributing 3,735 pills. No sentencing date had been set. The 20-year maximum identified in the announcement is potential punishment, not an imposed term.

Llerena paid people to pose as patients and obtain unnecessary oxycodone prescriptions from South Florida clinics and doctors. He brought the recruits and prescriptions to pharmacies operated by pharmacist Olushola Yusuf, who had been convicted in a separate trial earlier in the year. Yusuf kept a list of Llerena's recruits, and Llerena paid above-market cash prices for the drugs. He then paid recruits, often through Zelle, and resold the pills. These facts distinguish the clinical and pharmacy nexus from a generic street-trafficking case.

Why it matters

Recruiter-controlled patient groups and coordinated payment patterns can expose diversion involving apparently valid prescriptions. Clinics and pharmacies need to assess the surrounding conduct as well as the prescription document.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, HHS-OIG, DEA, FBI

Entities

Jose Llerena, Olushola Yusuf

Action type

Criminal resolution

Event date

Oct 14, 2026

Alleged conduct

Paying purported patients to obtain unnecessary oxycodone prescriptions, obtaining pills through participating pharmacies and reselling them.

Resolution

Llerena pleaded guilty; sentencing date not set. Conspiracy quantity exceeded 87,000 pills; personal quantity was 3,735.

What to do nextReview patterns involving repeated escorts or recruiters, coordinated patient groups, unusual cash pricing and common payment arrangements. Document investigation and resolution of prescribing and dispensing concerns through the established clinical and compliance process.

• Investigate recruiter-controlled patient and prescription patterns.
• Consider cash and payment coordination when resolving diversion concerns.

1. Recommended internal target: identify the process for escalating suspected patient recruitment and coordinated controlled-substance access across clinics and pharmacies. Compliance · due Oct 23, 2026
2. Recommended internal target: examine selected recruiter-linked patterns with clinical and pharmacy leaders and document the basis for any resulting controls. Clinical Operations · due Oct 30, 2026

Permalink: #llerena-opioid-patient-recruiter-plea · Development ID GC-2026-0356

Somerset settles olopatadine labeling claims for $4 million plus interest

Summary

Somerset's executed agreement requires $4 million plus interest as restitution over prescription labeling after an OTC switch. It resolves common-law payment-by-mistake and unjust-enrichment claims without admitting liability. False Claims Act liability is expressly reserved rather than released.

What changed

Somerset Lifesciences executed a settlement effective October 15, announced by DOJ October 16, requiring $4 million plus interest, all designated as restitution. The agreement resolves civil monetary claims under the common-law theories of payment by mistake and unjust enrichment. Paragraph 3(b) expressly reserves False Claims Act liability; this is not an FCA release. Recital E states that the agreement is not an admission of liability by Somerset. That executed provision supplies the controlling qualification to the press release's generic reference to admissions. The agreement requires payment within 10 business days after its effective date but does not state an interest rate or commencement date.

The covered conduct concerns Somerset's manufacturing, labeling, marketing and sale of olopatadine hydrochloride ophthalmic solution USP, 0.1% as prescription-only from February 14, 2020 through October 17, 2023. Its reference product, Pataday Twice Daily Relief 0.1%, received approval for a full OTC switch on or about February 14, 2020. The agreement describes the resulting requirement, absent a meaningful difference between the prescription and OTC versions, to update the generic's labeling or seek withdrawal of its application. The government contended that Somerset continued prescription-only sales, causing Medicare payments for a product no longer eligible for Part D coverage. These remain the government's contentions, not an adjudicated liability finding.

Why it matters

Rx-to-OTC changes can affect reimbursement eligibility while product and claims systems still carry prescription-only indicators. The agreement also shows why the actual release matters: settlement of common-law claims does not establish that FCA exposure was resolved.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks, Health-tech

Jurisdiction

Federal

Agencies

DOJ, HHS-OIG

Entities

Somerset Lifesciences Inc.

Action type

Settlement

Event date

Oct 15, 2026

Alleged conduct

Continuing prescription-only olopatadine labeling and sales after the reference product's OTC switch, allegedly causing mistaken Medicare payments during February 14, 2020 through October 17, 2023.

Resolution

Agreement effective October 15 requires $4 million plus unspecified interest, all restitution. It releases payment-by-mistake and unjust-enrichment claims, expressly reserves FCA liability and contains no admission of liability.

What to do nextReview how authoritative Rx-to-OTC changes reach product records, formulary information and reimbursement edits. Reconcile relevant status transitions and associated claims, referring possible overpayments for a documented legal assessment. Preserve the agreement's no-admission provision and express FCA reservation when describing this resolution. The playbook dates are recommended internal targets.

• Connect product-label changes with reimbursement eligibility controls.
• Retain authoritative support for product-status and claims-system changes.
• Read the actual release and reserved claims before describing the legal scope of a settlement.
• Distinguish government contentions from admissions or adjudicated findings.

1. Recommended internal target: identify responsibility for receiving and implementing Rx-to-OTC changes across pharmacy product records and reimbursement systems. Revenue Cycle · due Oct 23, 2026
2. Recommended internal target: reconcile relevant product-status changes with paid claims and document any unresolved reimbursement questions for Legal, distinguishing common-law settlement terms from reserved FCA liability. Compliance · due Oct 30, 2026

Permalink: #somerset-olopatadine-otc-labeling-settlement · Development ID GC-2026-0357

Free State Pharmacy defendants receive 24-month sentences

Summary

DOJ announced 24-month sentences for Steven Churchill and Samson Solomon in a pharmacy scheme that caused $897,405 in Medicare payments. Concealed ownership, inaccurate retail-pharmacy representations, unsupported telemedicine prescriptions and unsolicited shipments formed the reported conduct. A third defendant awaits sentencing.

What changed

An October 16 announcement reports that Steven Anthony Churchill and Samson Kollelil Solomon each received 24 months in prison after pleading guilty to conspiracy to commit healthcare fraud, mail fraud and wire fraud. Co-defendant Fawn Lickteig is scheduled for sentencing November 10, 2026. The release does not give the dates on which Churchill and Solomon were sentenced, so October 16 is the announcement date used here. Between September 2020 and February 2021, 2,699 false claims caused Medicare to pay Free State Pharmacy $897,405.

Churchill bought the pharmacy under another person's name, and it operated as a mail-order business while representing itself to Medicare as a retail pharmacy. It obtained patient information through telemedicine companies and shipped medications despite absent physical examinations or proper telemedicine visits. Patients called about unexpected products and returned shipments. The pharmacy prioritized prescriptions by expected Medicare profit, with high-dollar dermatology products predominating. Lickteig's consulting company handled government applications, connecting enrollment accuracy with the pharmacy's actual operating model.

Why it matters

Ownership, enrollment classification, prescribing support and shipment complaints can expose the same scheme. A pharmacy's reimbursement profile should be consistent with its actual business operations and patient relationships.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, FBI, HHS-OIG

Entities

Steven Anthony Churchill, Samson Kollelil Solomon, Fawn Lickteig, Free State Pharmacy

Action type

Criminal resolution

Event date

Oct 16, 2026

Alleged conduct

Concealed pharmacy ownership, inaccurate enrollment representations and unnecessary prescriptions supporting fraudulent Medicare claims.

Resolution

October 16 announcement of two 24-month sentences; exact sentence dates absent. Lickteig sentencing scheduled November 10. Medicare paid $897,405.

What to do nextCompare pharmacy enrollment representations with ownership and fulfillment practices. Review unsolicited-shipment complaints, high-margin product concentration and telemedicine encounter support together.

• Match enrollment representations to actual pharmacy operations.
• Connect shipment complaints and returns with prescribing and billing review.

1. Recommended internal target: reconcile pharmacy ownership and retail or mail-order enrollment representations with actual operations. Provider Enrollment · due Oct 23, 2026
2. Recommended internal target: trace selected high-margin prescriptions and returned shipments to legitimate encounters, patient requests and claims support. Compliance · due Oct 30, 2026

Permalink: #free-state-pharmacy-churchill-solomon-sentences · Development ID GC-2026-0358

Physician and practices settle insured-patient and unperformed-test allegations

Summary

Steven Murphy and two practices agreed to pay $866,539 and accept a three-year federal-program exclusion. Allegations involved uninsured-program claims despite insurance information in patient files, and billing laboratory components that could not be performed because required reagents were unavailable.

What changed

DOJ announced October 16 that Steven Murphy, M.D., Murphy Medical Associates, LLC, and Diagnostic and Medical Specialists of Greenwich, LLC agreed to pay $866,539 to resolve federal and state False Claims Act allegations. The settlement covers September 2019 through April 2022 and includes an agreed three-year exclusion from all federal healthcare programs. The announcement does not provide the exclusion's start date. The reported conduct remains described as government allegations, rather than a criminal conviction.

The government alleged that the practices billed HRSA's COVID-19 Uninsured Program despite possessing insurance cards or other records showing coverage, and changed internal insurance identifiers to Covid19 HRSA Uninsured before submitting claims. A separate allegation concerned in-house blood-test panels: individual components were billed to Medicare or Medicaid even when the practices lacked the reagents needed to perform those tests. The case presents two distinct reconciliation failures, between source insurance records and claim attestations, and between actual laboratory performance and billed panel components.

Why it matters

An internal payer label does not establish uninsured status, and an ordered panel does not prove every component was performed. Exclusion terms also require separate operational attention beyond the monetary settlement.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, Connecticut Office of the Attorney General, HHS-OIG, FBI

Entities

Steven Murphy, M.D., Murphy Medical Associates, LLC, Diagnostic and Medical Specialists of Greenwich, LLC

Action type

Settlement

Event date

Oct 16, 2026

Alleged conduct

Billing the HRSA Uninsured Program for insured patients and billing Medicare or Medicaid for laboratory components not actually performed.

Resolution

$866,539 settlement and agreed three-year federal healthcare-program exclusion announced. Exclusion commencement and agreement execution dates not provided.

What to do nextReconcile eligibility attestations with underlying coverage records and laboratory claims with actual test completion. Verify any relevant exclusion effective dates through authoritative records before implementing participation decisions.

• Validate eligibility attestations against original coverage evidence.
• Bill laboratory components only when performance is supported.
• Confirm exclusion effective dates separately from the announcement.

1. Recommended internal target: review controls preventing internal payer overrides from bypassing insurance evidence used for program eligibility attestations. Patient Access · due Oct 23, 2026
2. Recommended internal target: reconcile selected billed laboratory components with completed results and reagent availability, and assess exclusion-related exposure if these entities are connected to operations. Compliance · due Oct 30, 2026

Permalink: #murphy-uninsured-program-laboratory-settlement · Development ID GC-2026-0359

DEA orders nurse practitioner registration revoked after default and loss of state authority

Summary

DEA’s October14 published administrative order revokes Katherine Curtis’s registration effective November13. It rests on loss of Indiana authority and public-interest findings following default. The case illustrates credential and prescribing controls; it is not a criminal conviction.

What changed

DEA published its decision and order concerning Indiana nurse practitioner Katherine Curtis on October 14. Signed October 5, the order revokes her DEA registration and denies the specified pending renewal, modification and additional Indiana registration applications effective November 13. Curtis did not timely request a hearing or answer the order to show cause; DEA therefore found her in default and treated the factual allegations as admitted under its administrative rules. The decision is an administrative registration action, not a reported criminal conviction.

DEA found that Curtis lacked Indiana authority to handle controlled substances and treated that loss as an independent basis for revocation. It also found repeated controlled-substance prescribing outside legitimate medical purpose and the usual course of practice, including inadequate evaluations and records, unsupported dangerous combinations and excessive dosing. The order discusses Indiana-specific telehealth relationship, in-person opioid examination and INSPECT requirements and explains that the admitted conduct weighed against continued registration. Those state-law findings should not be restated as a newly adopted nationwide telehealth rule.

Why it matters

A federal registration does not replace the underlying state authority needed to prescribe. Credential-expiration alerts, clinical documentation review and prompt handling of agency notices are separate controls; default can determine how allegations are treated in an administrative proceeding.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Primary owner

Compliance

Agencies

DEA

Entities

Katherine Curtis, N.P.

Action type

Administrative order

Event date

Oct 14, 2026

Alleged conduct

Administrative findings following default concerned loss of Indiana controlled-substance authority and prescribing outside legitimate medical purpose and the usual course of professional practice.

Resolution

Order signed October5 and published October14 revokes the DEA registration and denies specified pending applications effective November13,2026. No criminal conviction is reported by this source.

What to do nextReconcile prescriber state authority and DEA registrations, review controlled-substance documentation and applicable state telehealth requirements, and route any agency notice to counsel immediately. Use the case as a control test rather than assuming every jurisdiction has Indiana’s requirements. Internal dates below are recommended targets.

• Keep state authority and federal registration status reconciled.
• Review prescribing documentation and state-specific requirements; promptly escalate administrative notices.

1. Recommended internal target: reconcile state prescribing authority, controlled-substance registrations and DEA credentials for selected prescribers. Compliance · due Oct 23, 2026
2. Recommended internal target: sample controlled-substance evaluations and state-specific telehealth/monitoring compliance, with counsel escalation for gaps. Clinical Operations · due Oct 30, 2026

Permalink: #dea-curtis-registration-revocation-order · Development ID GC-2026-0371

Later CDPH export lists eight actions issued October 12–16 totaling $77,000

Summary

A CDPH dashboard refreshed October 20 lists eight actions issued October 12–16, with $77,000 in initial and final assessed amounts. Two administrative staffing penalties account for $50,000. The records concern earlier violation periods and provide a retrospective view, without establishing the dataset or case status as it stood October 17.

What changed

CDPH’s State Enforcement Actions dashboard export, read after its October 20 refresh, lists eight records with penalty issue dates from October 12 through 16 within an October 11–17 query. The export contains six citations and two administrative penalties, totaling $77,000 in both the initial and final assessment fields. Seven records concern skilled nursing facilities and one concerns an intermediate care facility for people with developmental disabilities requiring nursing care. All eight show Open dispositions in the later-refreshed export. The date filter identifies issuance dates; it does not establish which records or statuses were available by October 17.

The two $25,000 administrative penalties concern Menifee Lakes Post Acute and Trabuco Hills Post Acute and carry the export’s “DHPPD: 2 - 11 Days” category. Their violation periods run from December 30, 2022 through March 31, 2023, and December 31, 2023 through March 31, 2024, respectively. The other six records include two patient-care citations, two categorized as abuse not self-reported by the facility, one staffing citation and one categorized as Other. Their listed violation dates also precede issuance. These entries identify assessed enforcement metadata; the category, Open disposition and balance fields do not supply incident narratives or establish payment or appeal outcomes.

Why it matters

Issuance during a weekly review window can concern conduct from much earlier periods. Facility controls should be reviewed against the actual citation and its relevant operational period, with assessment, balance and procedural status kept separate.

Response type

Assess

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

California

Primary owner

Compliance

Agencies

CDPH

Entities

Rosewood Post Acute, Cerritos Vista Healthcare Center, Kei-Ai South Bay Healthcare Center, LOYD'S LIBERTY HOMES, INC. - HOLLY OAK, Torrance Care Center West, Inc., Emmanuel Post Acute Care - Hayward, Menifee Lakes Post Acute, Trabuco Hills Post Acute

Action type

Civil monetary penalty

Event date

Oct 16, 2026

Alleged conduct

Export categories include patient care, abuse not self-reported, staffing, Other and DHPPD: 2 - 11 Days. Full citation narratives are not supplied by these rows.

Resolution

Eight historical issue-date records list $77,000 initial and final assessments and Open dispositions in the October20 refreshed export; contemporaneous October17 status and appeal outcomes are not established.

What to do nextObtain the six citation documents and the two administrative-penalty records before drawing facility-specific conclusions. Review patient-care escalation, abuse reporting and staffing documentation against the actual findings, and preserve each source’s issue date, violation period and refresh date.

• Separate penalty issuance from the period of the underlying violation.
• Read operative citation documents before drawing incident-specific conclusions.

Permalink: #cdph-later-refresh-eight-october-issue-date-actions · Development ID GC-2026-0426

Chein petition seeks revocation over alleged practice and probation failures

Summary

An October 13 amended accusation and petition asks the Medical Board to revoke Connie S. L. Chein's probation over alleged practice and compliance failures. The pleading builds on earlier stayed discipline; it does not establish that the requested revocation has been imposed.

What changed

A First Amended Accusation and Petition to Revoke Probation signed October 13, 2026 asks the Medical Board of California to revoke Connie S. L. Chein's probation and impose the previously stayed disciplinary order. In case 800-2025-123091, the pleading states nine causes to revoke probation and four additional causes for discipline. It alleges practice without the required clinical-competence clearance, failures involving notification, reporting, education, specialist follow-up and cost payments, and false compliance documents and other unprofessional conduct. These remain allegations and requested relief; the pleading is not a new order granting revocation.

The petition builds on a Board decision effective June 20, 2025 that stayed revocation and imposed five years of probation. A decision after Superior Court remand effective January 29, 2026 maintained application across practice specialties. The amended pleading also reports that an April 16, 2026 interim order suspended the certificate, a separate action from the revocation now requested. Probation Condition 15 required successful completion of a clinical competence assessment program and written Board notification before practice could resume. The new pleading alleges that Chein continued to see patients and prescribe before meeting those requirements and did not successfully complete the assessment. Those allegations concern compliance with an existing restriction, rather than a new general requirement for physicians to complete an assessment program.

Why it matters

For teams tracking physician probation, the case illustrates why the exact practice restriction, completion evidence and written release need to be checked alongside notification and reporting obligations.

Response type

Assess

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

California

Primary owner

Legal

Agencies

Medical Board of California

Entities

Connie S. L. Chein, M.D.

Action type

Administrative accusation

Event date

Oct 13, 2026

Alleged conduct

Alleged practice without the required clinical-competence clearance, failures to satisfy probation conditions, false compliance documents and unprofessional conduct.

Resolution

Amended accusation and petition requesting revocation; the requested relief is not established as imposed by this document.

What to do nextAssess how applicable physician probation conditions, completion documents and required written permissions are tracked. Distinguish the allegations and requested relief in a new petition from the restrictions imposed by an existing order.

• Check the exact restrictions and written permission required by an applicable probation order.
• Track evidence of completion, notifications and reporting separately from the procedural status of a petition.

Permalink: #mbc-chein-amended-probation-revocation-petition · Development ID GC-2026-0427

Spivak petition alleges failures in probation completion, testing and reporting

Summary

A petition signed October 13 asks the Medical Board to revoke Ryan Matthew Spivak's probation, alleging failures involving required programs, testing and quarterly declarations. The filing seeks further discipline under existing probation terms; it does not establish a new revocation or a positive drug test.

What changed

A Medical Board of California petition signed October 13, 2026 seeks revocation of Ryan Matthew Spivak's probation in case 800-2023-103933. Its six causes concern an ethics program, a clinical competence assessment program, biological-fluid testing, quarterly declarations, a probation-violation condition and the requirement to obey laws. The petition requests a hearing followed by revocation of probation and imposition of the stayed disciplinary order, or revocation or suspension of the certificate, together with action on supervisory authority. It is a request for discipline, not a new decision adjudicating the alleged violations or imposing the requested revocation.

The allegations distinguish participation from timely completion and proof. The petition says Spivak attended an ethics-course follow-up in May 2026 but submitted the participation letter late, and that required charts had not been timely submitted to the clinical competence program as of September 1, 2026. It also alleges missed daily testing check-ins, failure to provide two selected samples and late quarterly declarations. A missed sample is not itself a positive test result. The petition relies on earlier discipline with stayed revocations and probation; its current allegations do not turn the attached historical decisions into new October 2026 adjudications. The completion, testing and reporting conditions are specific to the respondent's probation, rather than new deadlines for physicians generally.

Why it matters

Probation monitoring can require separate evidence of enrollment, completion, timely reporting and testing participation. This petition illustrates why attendance alone does not establish compliance with every applicable condition.

Response type

Assess

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

California

Primary owner

Legal

Agencies

Medical Board of California

Entities

Ryan Matthew Spivak, M.D.

Action type

Administrative accusation

Event date

Oct 13, 2026

Alleged conduct

Alleged failures involving ethics-program completion and proof, clinical-competence-program requirements, testing participation and quarterly declarations, with related probation-violation and obey-laws causes.

Resolution

Petition requesting revocation or suspension; it does not establish that the alleged violations have been adjudicated or the requested relief imposed.

What to do nextAssess tracking of applicable probation-program completion, supporting documents, testing participation and quarterly submissions. Check the actual order and any authorized extensions; distinguish missed testing from a positive result and a new petition from an issued disciplinary decision.

• Track program participation, completion and proof as separate requirements of an applicable order.
• Distinguish a missed sample from a positive test and a petition from an issued decision.

Permalink: #mbc-spivak-probation-completion-testing-petition · Development ID GC-2026-0428

Indictment alleges stolen identity used to obtain MassHealth benefits

Summary

An October 13 announcement reports an indictment alleging that Santo Escolastico Cuello used another person's identity to obtain approximately $162,180 in MassHealth benefits. The case concerns beneficiary identity and eligibility representations. It does not establish wrongdoing by a treating provider.

What changed

The Massachusetts U.S. Attorney's Office announced on October 13 that Santo Escolastico Cuello had been indicted on three counts of making false statements relating to healthcare matters and one count of aggravated identity theft. A criminal complaint had previously been filed in June 2026. The announcement reports the indictment as the new procedural development but does not give its exact return date. Arraignment was to occur later, and the charges remain allegations subject to the presumption of innocence.

According to the government, Cuello used a U.S. citizen's stolen identity and Social Security number to apply for Massachusetts healthcare benefits and submitted a sworn affidavit falsely representing citizenship. The complaint alleges approximately $162,180 in MassHealth benefits obtained using that identity. The source also alleges use of the same identity during earlier law-enforcement encounters. It does not describe a provider billing scheme, a conviction or an imposed restitution award.

Why it matters

The relevant control issue is resolving identity and eligibility discrepancies through established procedures. An allegation against a beneficiary does not itself establish provider misconduct or authorize new screening requirements.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, HSI, HHS-OIG

Entities

Santo Escolastico Cuello

Action type

Criminal charge

Event date

Oct 13, 2026

Alleged conduct

Using a stolen identity and false healthcare-benefit representations to obtain approximately $162,180 in MassHealth benefits.

Resolution

Indictment announced October 13; exact indictment date not supplied. No conviction or sentence reported.

What to do nextFor organizations handling enrollment or benefit applications, review identity-mismatch escalation and documentation procedures. Use established payer and legal requirements when resolving discrepancies, and avoid inferring provider fraud from this indictment.

• Escalate identity discrepancies using established enrollment procedures.
• Distinguish beneficiary allegations from provider billing misconduct.

1. Recommended internal target: identify the approved process for escalating inconsistent identity information during benefit enrollment or application assistance. Patient Access · due Oct 23, 2026
2. Recommended internal target: review a small sample of resolved identity discrepancies for consistent documentation, appropriate payer coordination and access safeguards. Compliance · due Oct 30, 2026

Permalink: #cuello-masshealth-identity-fraud-indictment · Development ID GC-2026-0353

Counseling-center owner sentenced for retaining withheld payroll taxes

Summary

Mari Alexander received three years' probation and a $1,048,840 restitution order after failing to remit payroll taxes from a Tennessee mental-health counseling business. The new event is the October 13 sentence. The conduct concerns employment-tax administration rather than clinical billing.

What changed

Mari Alexander was sentenced October 13 to three years' probation and ordered to pay $1,048,840 in restitution to the United States. She had pleaded guilty April 15, 2026 to willful failure to account for and pay over employment taxes. The article was published October 13 and updated October 15; the update does not move the sentencing event to October 15. The restitution order is distinct from a healthcare-program repayment or patient-care sanction.

Alexander was sole owner and president of a mental-health counseling center with multiple Tennessee locations and controlled its financial affairs. From 2015 through 2020, she failed to remit withheld Social Security, Medicare and federal income taxes and failed to file more than 20 quarterly employment-tax returns. DOJ described a tax loss exceeding $1 million. The healthcare connection is the employer's counseling business, while the operative control issue is custody, remittance and independent confirmation of withheld employment taxes.

Why it matters

Healthcare organizations can face significant enforcement exposure through ordinary finance functions. Payroll processing alone does not establish that withheld taxes were deposited or returns filed.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, IRS-CI

Entities

Mari Alexander

Action type

Criminal resolution

Event date

Oct 13, 2026

Alleged conduct

Willfully failing to remit withheld employment taxes or file more than 20 quarterly returns for a mental-health counseling business.

Resolution

Three years' probation and $1,048,840 restitution following an April guilty plea.

What to do nextRequire independent confirmation of payroll-tax deposits and quarterly filings, reconcile them to payroll liabilities, and escalate overdue remittances or missing returns to leadership.

• Confirm actual tax deposits and filed returns independently.
• Escalate withholding liabilities that remain unpaid.

1. Recommended internal target: reconcile current payroll-tax liabilities with deposit confirmations and filed quarterly returns. Finance · due Oct 23, 2026
2. Recommended internal target: establish independent review of deposits, filing confirmations and exception escalation outside the person controlling payroll disbursements. Executive Leadership · due Oct 30, 2026

Permalink: #mari-alexander-counseling-center-payroll-tax-sentence · Development ID GC-2026-0360

Pharmacy-robbery crew co-leader receives 140 months in prison

Summary

Ashley Gause received 140 months in prison after a conviction involving pharmacy robberies and distribution of stolen controlled substances. The crew also targeted cellphone stores. The reported $300,000 covers mixed proceeds and prescription drugs, rather than a separately quantified drug loss or restitution order.

What changed

Ashley Gause was sentenced October 13 to 140 months in federal prison and three years of supervised release. A jury had convicted her October 28, 2025 of robbery conspiracy, controlled-substance distribution conspiracy arising from pharmacy robberies, and eight individual robbery counts. The new event is her sentence, not the earlier conviction. DOJ's reference to $300,000 combines proceeds and prescription drugs from the crew's activities; it is not identified as a drug-only valuation or restitution judgment.

From May 2020 through May 2021, the crew targeted pharmacies and cellphone stores in the District of Columbia, Maryland, Virginia and New Jersey to obtain prescription drugs and phones for resale. Multiple incidents involved firearms pointed at victims. The explicit theft and subsequent distribution of pharmacy controlled substances supply the healthcare nexus. The release reports criminal conduct against pharmacy employees and businesses, rather than dispensing violations by the victim pharmacies.

Why it matters

Pharmacy security and diversion response intersect when robbery places controlled substances into illegal distribution. Employee safety, inventory reconciliation and preservation of evidence need coordinated procedures.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, FBI, Metropolitan Police Department

Entities

Ashley Gause

Action type

Criminal resolution

Event date

Oct 13, 2026

Alleged conduct

Co-leading robberies of pharmacies and cellphone stores and conspiring to distribute controlled substances stolen from pharmacies.

Resolution

140 months in prison and three years of supervised release after jury conviction. No restitution amount stated.

What to do nextReview robbery-response training, employee safety measures and postincident controlled-substance reconciliation. Preserve surveillance and inventory evidence and route losses through applicable established reporting procedures.

• Coordinate employee safety and controlled-substance diversion response.
• Preserve surveillance and inventory evidence after pharmacy robberies.

1. Recommended internal target: confirm pharmacy robbery response roles, employee safety training and access to emergency assistance. Clinical Operations · due Oct 23, 2026
2. Recommended internal target: review the postincident process for inventory reconciliation, evidence preservation and legally required controlled-substance loss reporting. Compliance · due Oct 30, 2026

Permalink: #gause-pharmacy-robbery-diversion-sentence · Development ID GC-2026-0361

Miracle-Ear and foundation settle PPP affiliation allegations for $6.47 million

Summary

Miracle-Ear and its foundation agreed to pay $6,473,222 over alleged PPP ineligibility tied to their multinational corporate affiliations. The government also challenged use of a franchise exemption. The hearing-aid sector connection is explicit, while the conduct concerns financial-assistance certifications rather than clinical claims.

What changed

DOJ announced October 16 that Miracle-Ear, Inc. and Miracle-Ear Foundation agreed to pay $6,473,222 to resolve False Claims Act allegations concerning three Paycheck Protection Program loans. Miracle-Ear received two $1,962,000 loans, in June 2020 and February 2021, and the foundation received $58,100 in May 2020. The announcement states that they do not admit liability. The settlement amount should therefore be distinguished from the individual loan principal amounts and from an adjudicated fraud finding.

Miracle-Ear sells hearing aids through company and franchisee stores, while its foundation supplies free hearing aids to low-income individuals. The government alleged that their affiliation with Amplifon's multinational group made them ineligible under applicable employee-count rules. It also alleged that Miracle-Ear claimed an affiliation exemption for businesses operating as franchisees even though it issued franchises. Two whistleblower suits were resolved, and Blockquote, Inc. will receive $1,154,111.40. The case turns on the applicant's actual corporate role and affiliates, rather than its healthcare mission.

Why it matters

Healthcare businesses and affiliated nonprofits must support financial-assistance certifications using the applicable program rules and complete corporate relationships. Similar names or franchise involvement do not establish eligibility.

Response type

Validate

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

Federal

Agencies

DOJ, SBA

Entities

Miracle-Ear, Inc., Miracle-Ear Foundation

Action type

Settlement

Event date

Oct 16, 2026

Alleged conduct

Falsely certifying PPP eligibility despite corporate affiliations and allegedly misusing the franchise affiliation exemption.

Resolution

$6,473,222 settlement announced without admission of liability. Blockquote, Inc. whistleblower share is $1,154,111.40.

What to do nextFor organizations with relevant historical assistance, reconcile eligibility certifications to affiliate and employee-count analyses, exemption criteria and supporting records. Refer material discrepancies for counsel-directed review.

• Document program-specific affiliation and eligibility analyses.
• Distinguish a franchisor's role from a franchisee exemption.
• Retain the factual basis for assistance certifications.

1. Recommended internal target: identify relevant assistance certifications and locate the contemporaneous affiliate, employee-count and exemption analyses. Finance · due Oct 23, 2026
2. Recommended internal target: reconcile certifications with actual corporate relationships and applicant roles, documenting any unresolved eligibility questions for Legal. Legal · due Oct 30, 2026

Permalink: #miracle-ear-foundation-ppp-affiliation-settlement · Development ID GC-2026-0362

Nice to Know: South Carolina charges power of attorney over care resident’s funds

Summary

South Carolina announced charges against Dionne L. Robinson over alleged misuse of a residential-care resident’s funds and debit card. The account concerns alleged misuse of power of attorney; it does not allege wrongdoing by the care facility or establish guilt.

What changed

An October 13 South Carolina Attorney General release announced the arrest of Dionne L. Robinson on charges of exploitation of a vulnerable adult and financial transaction card fraud involving more than $500 in a six-month period. The office’s Vulnerable Adults and Medicaid Provider Fraud unit investigated the case, and Robinson was booked October 12. These are criminal charges; the release expressly preserves the presumption of innocence and reports no adjudication of guilt.

Investigators allege that Robinson improperly used the resident’s funds or assets while acting as power of attorney and used the resident’s debit card for her own benefit without permission. The person lived in a residential care facility at the time of the alleged misconduct. That setting provides a resident-protection connection, but the release does not identify Robinson as facility staff, accuse the facility of wrongdoing or announce a new duty for care providers.

Why it matters

For resident-protection teams, the case offers an example of alleged financial exploitation by a person holding power of attorney. A resident’s care setting and the role of the accused should be distinguished from institutional misconduct.

Response type

Monitor

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

South Carolina

Primary owner

Compliance

Affected functions

Compliance, Legal

Agencies

South Carolina Attorney General’s Office, Vulnerable Adults and Medicaid Provider Fraud unit

Entities

Dionne L. Robinson

Action type

Criminal charge

Event date

Oct 13, 2026

Alleged conduct

Alleged unauthorized use of a residential-care resident’s funds or assets by the resident’s power of attorney, including debit-card use for her own benefit.

Resolution

October 13 announcement of criminal charges and an October 12 booking; no adjudication of guilt reported.

What to do nextUse the account for resident-protection awareness where relevant to existing concerns about authority over a resident’s finances. Do not treat the reported charges as proof of guilt or as a new general compliance requirement.

• Distinguish alleged misuse of financial authority by a representative from wrongdoing attributed to a care facility.

Permalink: #south-carolina-robinson-resident-power-of-attorney-charges · Development ID GC-2026-0429

Nice to Know: South Carolina alleges financial exploitation of an assisted-living resident

Summary

A South Carolina release alleges that Paul M. Bostrom used power of attorney to divert more than $10,000 from an assisted-living resident. It reports criminal charges and a booking, without a conviction or an allegation that the facility participated.

What changed

South Carolina’s Attorney General announced October 13 that Paul M. Bostrom had been arrested on charges of exploitation of a vulnerable adult and breach of trust with fraudulent intent involving $10,000 or more. Bostrom was booked October 12 following a joint investigation by the Vulnerable Adults and Medicaid Provider Fraud unit and the Lexington Police Department. The release reports allegations and charging activity, and states that defendants are presumed innocent unless proved guilty.

Investigators allege that Bostrom used his position as power of attorney to convert the resident’s funds and assets for his own benefit, intending to permanently deprive the resident of them. The alleged amount exceeds $10,000, and the resident lived in an assisted living facility during the alleged misconduct. The release supplies a connection to resident financial protection, but does not identify Bostrom as a care provider or facility employee, attribute wrongdoing to the facility, or establish a new provider obligation.

Why it matters

The case may inform awareness of alleged financial exploitation involving a representative of an assisted-living resident. The allegation concerns misuse of financial authority, rather than a reported healthcare billing scheme or institutional enforcement resolution.

Response type

Monitor

Confidence

High

Who this affects

Health systems, Provider networks

Jurisdiction

South Carolina

Primary owner

Compliance

Affected functions

Compliance, Legal

Agencies

South Carolina Attorney General’s Office, Vulnerable Adults and Medicaid Provider Fraud unit, Lexington Police Department

Entities

Paul M. Bostrom

Action type

Criminal charge

Event date

Oct 13, 2026

Alleged conduct

Alleged conversion of more than $10,000 in funds and assets of an assisted-living resident by a person acting as the resident’s power of attorney.

Resolution

October 13 announcement of criminal charges and an October 12 booking; no adjudication of guilt reported.

What to do nextConsider the case in resident-protection awareness where existing concerns involve a representative’s control of finances. Keep criminal allegations separate from a finding of guilt and from any unsupported inference about facility responsibility.

• Identify the accused person’s actual role and preserve the distinction between alleged exploitation of a resident and misconduct by the resident’s facility.

Permalink: #south-carolina-bostrom-assisted-living-power-of-attorney-charges · Development ID GC-2026-0430